| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |